Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Denis Smith

Showing results (41-50 of 96) with videos related to

Pageof 10
Sort By:
Advances in Therapy|July 20, 2020
Evaluation of Nurses' and Patients' Overall Satisfaction with New and Previous Formulations of Octreotide Long-acting Release (Sandostatin LAR<sup>®</sup>): A French Observational StudyBrigitte Delemer, Thierry Nguyen-Tan-Hon, Romain Coriat, et al.
European Journal of Endocrinology|December 1, 2023
Characteristics and treatment options of glucagonomas: a national study from the French Group of Endocrine Tumors and ENDOCAN-RENATEN networkMarine Perrier, Mathias Brugel, Laura Gérard, et al.
Targeted Oncology|August 24, 2015
Secondary Metastases Resection After Bevacizumab Plus Irinotecan-Based Chemotherapy in First-Line Therapy of Metastatic Colorectal Cancer in a Real-Life Setting: Results of the ETNA CohortMagali Rouyer, Denis Smith, Christophe Laurent, et al.
Clinical Colorectal Cancer|January 12, 2019
Patterns of Use, Safety, and Effectiveness of Targeted Therapies in First-Line Treatment of Metastatic Colorectal Cancer According to Age: The STROMBOLI Cohort StudyAmandine Gouverneur, Juliette Coutureau, Jérémy Jové, et al.
Lasers in Medical Science|November 30, 2017
When is the best moment to apply photobiomodulation therapy (PBMT) when associated to a treadmill endurance-training program? A randomized, triple-blinded, placebo-controlled clinical trialEduardo Foschini Miranda, Shaiane Silva Tomazoni, Paulo Roberto Vicente de Paiva, et al.
European Journal of Cancer (Oxford, England : 1990)|December 3, 2014
Bevacizumab combined with 5-FU/streptozocin in patients with progressive metastatic well-differentiated pancreatic endocrine tumours (BETTER trial)--a phase II non-randomised trialMichel Ducreux, Laetitia Dahan, Denis Smith, et al.
Endocrine-Related Cancer|September 4, 2009
Phase III trial of chemotherapy using 5-fluorouracil and streptozotocin compared with interferon alpha for advanced carcinoid tumors: FNCLCC-FFCD 9710Laetitia Dahan, Frank Bonnetain, Philippe Rougier, et al.
Clinical and Translational Gastroenterology|January 21, 2026
Real-Time Characterization of Colonic Polyps: A Multicenter Prospective Study Evaluating the CAD-EYE System in Screening ColonoscopiesMarie Maigné, Maxime Saunier, Valentine Renaudeau, et al.
British Journal of Cancer|June 9, 2020
Intra-arterial hepatic beads loaded with irinotecan (DEBIRI) with mFOLFOX6 in unresectable liver metastases from colorectal cancer: a Phase 2 studySimon Pernot, Olivier Pellerin, Pascal Artru, et al.
Clinics and Research in Hepatology and Gastroenterology|September 13, 2011
Evaluation of efficacy and safety of FOLFIRI for elderly patients with gastric cancer: a first-line phase II studyMarianne Fonck, Réné Brunet, Yves Becouarn, et al.
Pageof 10

Showing results (41-50 of 96) with videos related to

Sort By:
Pageof 10
Advances in Therapy|July 20, 2020
Evaluation of Nurses' and Patients' Overall Satisfaction with New and Previous Formulations of Octreotide Long-acting Release (Sandostatin LAR<sup>®</sup>): A French Observational StudyBrigitte Delemer, Thierry Nguyen-Tan-Hon, Romain Coriat, et al.
European Journal of Endocrinology|December 1, 2023
Characteristics and treatment options of glucagonomas: a national study from the French Group of Endocrine Tumors and ENDOCAN-RENATEN networkMarine Perrier, Mathias Brugel, Laura Gérard, et al.
Targeted Oncology|August 24, 2015
Secondary Metastases Resection After Bevacizumab Plus Irinotecan-Based Chemotherapy in First-Line Therapy of Metastatic Colorectal Cancer in a Real-Life Setting: Results of the ETNA CohortMagali Rouyer, Denis Smith, Christophe Laurent, et al.
Clinical Colorectal Cancer|January 12, 2019
Patterns of Use, Safety, and Effectiveness of Targeted Therapies in First-Line Treatment of Metastatic Colorectal Cancer According to Age: The STROMBOLI Cohort StudyAmandine Gouverneur, Juliette Coutureau, Jérémy Jové, et al.
Lasers in Medical Science|November 30, 2017
When is the best moment to apply photobiomodulation therapy (PBMT) when associated to a treadmill endurance-training program? A randomized, triple-blinded, placebo-controlled clinical trialEduardo Foschini Miranda, Shaiane Silva Tomazoni, Paulo Roberto Vicente de Paiva, et al.
European Journal of Cancer (Oxford, England : 1990)|December 3, 2014
Bevacizumab combined with 5-FU/streptozocin in patients with progressive metastatic well-differentiated pancreatic endocrine tumours (BETTER trial)--a phase II non-randomised trialMichel Ducreux, Laetitia Dahan, Denis Smith, et al.
Endocrine-Related Cancer|September 4, 2009
Phase III trial of chemotherapy using 5-fluorouracil and streptozotocin compared with interferon alpha for advanced carcinoid tumors: FNCLCC-FFCD 9710Laetitia Dahan, Frank Bonnetain, Philippe Rougier, et al.
Clinical and Translational Gastroenterology|January 21, 2026
Real-Time Characterization of Colonic Polyps: A Multicenter Prospective Study Evaluating the CAD-EYE System in Screening ColonoscopiesMarie Maigné, Maxime Saunier, Valentine Renaudeau, et al.
British Journal of Cancer|June 9, 2020
Intra-arterial hepatic beads loaded with irinotecan (DEBIRI) with mFOLFOX6 in unresectable liver metastases from colorectal cancer: a Phase 2 studySimon Pernot, Olivier Pellerin, Pascal Artru, et al.
Clinics and Research in Hepatology and Gastroenterology|September 13, 2011
Evaluation of efficacy and safety of FOLFIRI for elderly patients with gastric cancer: a first-line phase II studyMarianne Fonck, Réné Brunet, Yves Becouarn, et al.
Pageof 10